2012China Modern DoctorRequires access

Rabeprazole combined with Mosapride on reflux esophagitis: clinical observation of 60 cases

Huang Baogen

Open publisher page 0 citations

Abstract

Objective To investigate the effect of rabeprazoloe combined with mosapride on reflux esophagitis.Methods 120 patients with reflux esophagitis were randomly divided into two groups.In treatment group,60 patients were given rabeprazole 20 mg,one time a day taken by mouth and mosapride 5 mg,three times a day taken by mouth,while in control group,60 patients were given famotidine 20 mg,two times a day taken orally and mosapride 5mg,three times a day taken orally.The treatment course of two groups was all 8 weeks.Gastroscope was performed in 8 weeks to observe the effective rate.Results The clinical effective rate in treatment group was 96.6%,while 78.3% respectively in control group.The differencebetween the two groups was statistically significant(P 0.01).Conclusion Rabeprazole combined with mosapride showes a better clinical efficacy than famotidine combined with mosapride in treatment of reflux esophagitis.

About this research paper

What this paper is about

Objective To investigate the effect of rabeprazoloe combined with mosapride on reflux esophagitis.Methods 120 patients with reflux esophagitis were randomly divided into two groups.In treatment group,60 patients were given rabeprazole 20 mg,one time a day taken by mouth and mosapride 5 mg,three times a day taken by mouth,while in control group,60 patients were given famotidine 20 mg,two times a day taken orally and mosapride 5mg,three times a day taken orally.The treatment course of two groups was all 8 weeks.Gastroscope was performed in 8 weeks to observe the effective rate.Results The clinical effective rate in treatment group was 96.6%,while 78.3% respectively in control group.The differencebetween the two groups was statistically significant(P 0.01).Conclusion Rabeprazole combined with mosapride showes a better clinical efficacy than famotidine combined with mosapride in treatment of reflux esophagitis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of rabeprazoloe combined with mosapride on reflux esophagitis.Methods 120 patients with reflux esophagitis were randomly divided into two groups.In treatment group,60 patients were given rabeprazole 20 mg,one time a day taken by mouth and mosapride 5 mg,three times a day taken by mouth,while in control group,60 patients were given famotidine 20 mg,two times a day taken orally and mosapride 5mg,three times a day taken orally.The treatment course of two groups was all 8 weeks.Gastroscope was performed in 8 weeks to observe the effective rate.Results The clinical effective rate in treatment group was 96.6%,while 78.3% respectively in control group.The differencebetween the two groups was statistically significant(P 0.01).Conclusion Rabeprazole combined with mosapride showes a better clinical efficacy than famotidine combined with mosapride in treatment of reflux esophagitis.

Key concepts: Mosapride, Medicine, Famotidine, Rabeprazole, Reflux esophagitis, Gastroenterology, Reflux, Esophagitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Rabeprazole combined with Mosapride on reflux esophagitis: clinical observation of 60 cases — Research Paper | ScholarLens